Nexalin Technology, Inc.

NXL Medical devices

Develops neurostimulation devices that treat anxiety, insomnia, and depression.

Jun 2026Revenue $217K/yrExpenses $9.34M/yr
No trendCash runway ≈ 2 months from Jun 2026
Figures by year

When will Nexalin Technology be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $217K and expenses $9.34M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$302K$8.69M−$8.39M
Dec 2024$169K$7.92M−$7.75M
Dec 2023$111K$5.81M−$5.70M
Dec 2022$1.32M$3.15M−$1.83M
Dec 2021$144K$6.16M−$6.02M